ExploreWatchlistsPricing
  1. US-listed companies
  2. Sonnet BioTherapeutics Holdings, Inc.
  3. Financials
  4. Operating margin (%)

Sonnet BioTherapeutics Holdings, Inc. (SONN)

Market cap
$1.26
P/E ratio
SummaryFinancials
Period EndOperating margin (%) YoY (%)
Sep 30, 2025-1,584.4-97.51%
Sep 30, 2024-63,617.9+238.53%
Sep 30, 2023-18,792.6+121.65%
Sep 30, 2022-8,478.3+63.44%
Sep 30, 2021-5,187.4+9625.16%
Dec 31, 2019-53.3+304.53%
Dec 31, 2018-13.2+4.35%
Dec 31, 2017-12.6+101.13%
Dec 31, 2016-6.3-76.81%
Dec 31, 2015-27.1+45.85%
Dec 31, 2014-18.6-66.74%
Dec 31, 2013-55.9+33.95%
Dec 31, 2012-41.7-14.56%
Dec 31, 2011-48.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat